-
Cylindromas_sun_protected_and_exposed
Study
EGAS00001002521
-
Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes
Study
EGAS00001005906
-
Hepatoblastoma tumoroid biobank as a key resource for tumour genetics
Study
EGAS00001008251
-
Sequencing of an adolescent patient with germline RET mutant alveolar rhabdomyosarcoma
Study
EGAS00001004359
-
Evolution and clinical impact of genetic epistasis within EGFR-mutant lung cancers
Study
EGAS00001002604
-
Reduced Representation Bisulfite Sequencing (RRBS) in various tissues to discover DNA methylation markers for the diagnosis of breast and ovarian cancer.
Study
EGAS00001002609
-
The evolutionary dynamics of human colorectal cancer using single-gland spatial multi-omic profiling of DNA, RNA and chromatin.
Study
EGAS00001005230
-
The evolution of hematopoietic cells under cancer therapy
Study
EGAS00001005234
-
Non-coding mutations reveal cancer driver cistromes in luminal breast cancer
Study
EGAS00001005235
-
TP53 variant detection analysis in high grade serous epithelial ovarian cancer
Study
EGAS00001004361
-
Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
Study
EGAS00001005981
-
Epigenetic analyses of methylation and nucleosome occupancy in cell-free DNA (cfNOMe)
Study
EGAS00001004370
-
Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis
Study
EGAS00001004373
-
Temporal stability of circulating microRNAs in human serum
Study
EGAS00001003221
-
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer
Study
EGAS00001005984
-
To determine the genomic profile of Triple Negative Breast Cancer patient-derived xenografts (PDX cohort)
Study
EGAS00001005995
-
Genomic landscape of oral cancers (Illumina WGS)
Study
EGAS00001003228
-
Functional Mapping of AKT Signaling and Biomarkers of Response From the FAIRLANE Trial of Neoadjuvant Ipatasertib Plus Paclitaxel for Triple-Negative Breast Cancer
Study
EGAS00001005892
-
Nucleosome footprinting in plasma cell-free DNA for diagnosis of ovarian cancer
Study
EGAS00001005361
-
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
Study
EGAS00001005952
-
Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring
Study
EGAS00001004406
-
Homologous recombination DNA repair deficiency and PARP inhibition activity in primary triple negative breast cancer
Study
EGAS00001004405
-
Fibroblast heterogeneity drives metastatic spread in breast cancer through distinct mechanisms
Study
EGAS00001003238
-
Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence (RNA-seq)
Study
EGAS00001006016
-
Personalised Mapping of Tumour Development in Synchronous Colorectal Cancer Patients
Study
EGAS00001004413
-
Genome analysis of early onset sporadic rectal cancer
Study
EGAS00001005970
-
Dual-mTOR inhibitor Rapalink-1 reduces prostate cancer patient-derived xenograft growth and alters tumor heterogeneity
Study
EGAS00001004431
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Patient-derived organoids as a novel tool to study cervical cancer
Study
EGAS00001004439
-
Methylome sequencing of cell-free DNA and RRBS of solid tissue
Study
EGAS00001006020
-
Single-cell analysis for metastatic gastric adenocarcinoma
Study
EGAS00001004443
-
Somatic_mutation_profiling_of_intestinal_crypts_from_IBD_Full_STDY
Study
EGAS00001003249
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Genomic characterization of co-existing biliary tract intraepithelial neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer
Study
EGAS00001005402
-
Identifying transcriptional programs underlying anti-EGFR small molecule response and resistance with TraCe-seq
Study
EGAS00001005405
-
The clinical utility of genomics in childhood cancer extends beyond targetable mutations
Study
EGAS00001006034
-
scRNA-seq of HGSC tumor and ascites
Study
EGAS00001004829
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Breast cohort
Study
EGAS00001004446
-
Genotyping by OncoArray and Global Screening Array for colorectal cancer risk prediction
Study
EGAS00001005411
-
Bulk RNA sequencing of Singapore colorectal cancer patients (SG-BULK)
Study
EGAS00001005978
-
NSCCG CRC GWAS data
Study
EGAS00001005412
-
Custom long non-coding RNA capture enhances detection sensitivity in different human sample types.
Study
EGAS00001005418
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
Evolutionary analysis of pancreatic neoplastic cysts through whole-exome and targeted sequencing
Study
EGAS00001004473
-
COIN CRC GWAS data
Study
EGAS00001005421
-
ANGIOPREDICT - an FP7-funded project enabling personalised medicine for patients with metastatic colorectal cancer.
Study
EGAS00001005423
-
Chromothripsis followed by circular recombination drives oncogene amplification in human cancer
Study
EGAS00001005424
-
Whole Genome sequencing of colorectal cancer patients (SG-BULK-3)
Study
EGAS00001006056
-
A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients
Study
EGAS00001004491